An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis
Clinical trial NCT04077567 · COMPLETED
Trial details
- NCT number
- NCT04077567
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2023-04-28
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.